Dietary chemopreventive compounds and ARE/EpRE signaling

Chi Chen1, A-N Tony Kong

  • 1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Insights

Dietary compounds like phenolic and sulfur-rich agents can induce detoxifying enzymes, offering a safe approach to cancer chemoprevention. These compounds activate the Nrf2 pathway, increasing the expression of protective enzymes against carcinogens.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Chemoprevention utilizes agents to prevent or reverse cancer development.
  • Dietary compounds are attractive for chemoprevention due to safety and acceptance.
  • Detoxifying enzymes play a crucial role in processing carcinogens.

Purpose of the Study:

  • To review the application of dietary detoxifying enzyme inducers in cancer chemoprevention.
  • To discuss the signaling events involved in this process.
  • To highlight the role of phenolic and sulfur-containing compounds.

Main Methods:

  • Review of scientific literature on chemoprevention and enzyme induction.
  • Analysis of signaling pathways regulating detoxifying enzymes.
  • Focus on the antioxidant response element (ARE)/electrophile response element (EpRE) and Nrf2 pathway.

Main Results:

  • Dietary compounds, particularly phenolic and sulfur-containing ones, induce detoxifying enzymes.
  • Regulation is mediated by the ARE/EpRE sequence and transcription factor Nrf2.
  • Activation of signaling pathways (oxidative stress, MAPK, PKC, PI3K) leads to Nrf2 nuclear translocation.

Conclusions:

  • Dietary detoxifying enzyme inducers are promising for cancer chemoprevention.
  • The Nrf2-ARE/EpRE pathway is central to their mechanism.
  • Understanding these signaling events can lead to novel chemopreventive strategies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...